Opexa Therapeutics Inc (NASDAQ:OPXA) Under Stockholder Investigation

An investigation for current long-term investors in shares of Opexa Therapeutics Inc (NASDAQ:OPXA) over potential wrongdoing by certain officers and directors of Opexa Therapeutics was announced and current long-term NASDAQ:OPXA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

Logo

San Diego, CA -- (SBWire) -- 10/14/2013 --An investigation on behalf of current long-term stockholders of shares of Opexa Therapeutics Inc (NASDAQ:OPXA) was announced concerning whether certain Opexa Therapeutics officers and directors possibly breached their fiduciary duties in connection with certain statements.

Investors who are current long-term stockholders of shares of Opexa Therapeutics Inc (NASDAQ:OPXA) have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Opexa Therapeutics officers and directors breached their fiduciary duties in connection with their conduct in seeking shareholders’ approval for the Company’s Amended and Restated 2010 Stock Incentive Plan.

In the Proxy Statement filed by Opexa Therapeutics Inc Company with the Securities and Exchange Commission the Board of Directors recommends that Opexa’s shareholders vote to approve an amendment to the Company’s Amended and Restated 2010 Stock Incentive Plan to increase the number of shares available for issuance thereunder by 3,000,000 shares.

According to the investigation the issuance of the additional shares could have a severe dilutive effect on the shares of Opexa Therapeutics Inc.

Opexa Therapeutics Inc (NASDAQ:OPXA) reported that its Net Loss increased from $5.97 million in 2011 to $8.93 million in 2012.

Shares of Opexa Therapeutics Inc (NASDAQ:OPXA) closed on Oct. 11, 2013 at $1.77 per share.

Those who purchased shares of Opexa Therapeutics Inc (NASDAQ:OPXA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Jacob Rosenfeld
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

Media Relations Contact

Jacob Rosenfeld
CR and Media Manager
Shareholders Foundation, Inc.
858-779-1554
http://www.ShareholdersFoundation.com

View this press release online at: http://rwire.com/357198